193 related articles for article (PubMed ID: 2201398)
21. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
Glas R; Ohlén C; Höglund P; Kärre K
J Exp Med; 1994 Feb; 179(2):661-72. PubMed ID: 8294874
[TBL] [Abstract][Full Text] [Related]
22. Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.
Maiorana A; Cesinaro AM; Fano RA; Collina G
Clin Exp Metastasis; 1995 Jan; 13(1):43-8. PubMed ID: 7820955
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of T-cell infiltrates, expression of beta 2-microglobulin and HLA-DR antigens in breast carcinoma.
Lucin K; Iternicka Z; Jonjić N
Pathol Res Pract; 1994 Dec; 190(12):1134-40. PubMed ID: 7792204
[TBL] [Abstract][Full Text] [Related]
24. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
Carrel S; Schmidt-Kessen A; Giuffrè L
Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
[TBL] [Abstract][Full Text] [Related]
25. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
Bhan AK; DesMarais CL
J Natl Cancer Inst; 1983 Sep; 71(3):507-16. PubMed ID: 6193308
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.
Ruiz-Cabello F; Lopez Nevot MA; Gutierrez J; Oliva MR; Romero C; Ferron A; Esteban F; Huelin C; Piris MA; Rivas C
Clin Exp Metastasis; 1989; 7(2):213-26. PubMed ID: 2493352
[TBL] [Abstract][Full Text] [Related]
27. Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
Concha A; Ruiz-Cabello F; Cabrera T; Nogales F; Collado A; Garrido F
Eur J Immunogenet; 1995 Aug; 22(4):299-310. PubMed ID: 7495782
[TBL] [Abstract][Full Text] [Related]
28. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
29. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
Apasov S; Sitkovsky M
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies as a tool for phylogenetic studies of major histocompatibility antigens and beta 2-microglobulin.
Teillaud JL; Crevat D; Chardon P; Kalil J; Goujet-Zalc C; Mahouy G; Vaiman M; Fellous M; Pious D
Immunogenetics; 1982; 15(4):377-84. PubMed ID: 6176537
[TBL] [Abstract][Full Text] [Related]
31. Major histocompatibility complex (MHC)-I and MHC-II expression in Hodgkin's disease in relation to the presence of Epstein-Barr Virus (EBV).
Tzardi M; Kouvidou C; Papakonstantinou E; Datseris G; Darivianaki K; Karidi E; Eliopoulos G; Delidis G; Rontogianni D; Kanavaros P
Anticancer Res; 1996; 16(2):827-31. PubMed ID: 8687136
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies against beta 2-microglobulin-free HLA antigens in AIDS patients.
Borghi MO; De Santis C; Barcellini W; Lopalco L; Fain C; Lazzarin A; Siccardi AG; Meroni PL; Zanussi C; Beretta A
J Acquir Immune Defic Syndr (1988); 1993 Oct; 6(10):1114-9. PubMed ID: 8410667
[TBL] [Abstract][Full Text] [Related]
33. Modulated expression of human leucocyte antigen class I and class II determinants in hyperplastic and malignant human prostatic epithelium.
Sharpe JC; Abel PD; Gilbertson JA; Brawn P; Foster CS
Br J Urol; 1994 Nov; 74(5):609-16. PubMed ID: 7530126
[TBL] [Abstract][Full Text] [Related]
34. Loss of HLA heavy chain and beta 2-microglobulin in HLA negative tumours.
Cabrera T; Concha A; Ruiz-Cabello F; Garrido F
Scand J Immunol; 1991 Aug; 34(2):147-52. PubMed ID: 1866599
[TBL] [Abstract][Full Text] [Related]
35. Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines.
Lin X; Wang X; Capek HL; Simone LC; Tuli A; Morris CR; Reber AJ; Solheim JC
Cancer Immunol Immunother; 2009 May; 58(5):729-36. PubMed ID: 18828016
[TBL] [Abstract][Full Text] [Related]
36. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.
Glas R; Franksson L; Ohlén C; Höglund P; Koller B; Ljunggren HG; Kärre K
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11381-5. PubMed ID: 1454824
[TBL] [Abstract][Full Text] [Related]
37. Differential effect of anti-beta 2-microglobulin on IL 2 production and IL 2 receptor expression in the primary mixed lymphocyte culture reaction.
Chouaib S; Welte K; Dupont B
J Immunol; 1985 Feb; 134(2):940-8. PubMed ID: 3155544
[TBL] [Abstract][Full Text] [Related]
38. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer.
Kaklamanis L; Leek R; Koukourakis M; Gatter KC; Harris AL
Cancer Res; 1995 Nov; 55(22):5191-4. PubMed ID: 7585572
[TBL] [Abstract][Full Text] [Related]
39. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
40. MHC antigens on human tumors.
Ruiz-Cabello F; Klein E; Garrido F
Immunol Lett; 1991 Aug; 29(3):181-9. PubMed ID: 1769705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
